Law.com International: As China Reopens, Will ‘China Bull’ Lawyers Finally Be Vindicated?

January 11, 2023

O’Melveny recently represented Cryofocus Medtech (Shanghai) Co., Ltd. (“Cryofocus”) (6922.HK) in its initial public offering and listing of H shares on the Main Board of the Hong Kong Stock Exchange. O’Melveny advised Cryofocus on both US and Hong Kong laws and drafted its prospectus.

Law.com International subscribers can read the full article here.